Verrotti A - Search Results

1

Moving beyond sodium valproate: choosing the right anti-epileptic drug in children.

Balagura G, Iapadre G, Verrotti A, Striano P. Balagura G, et al. Among authors: verrotti a. Expert Opin Pharmacother. 2019 Aug;20(12):1449-1456. doi: 10.1080/14656566.2019.1617850. Epub 2019 May 17. Expert Opin Pharmacother. 2019. PMID: 31099271 Review.

2

Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants.

Verrotti A, Domizio S, Angelozzi B, Sabatino G, Morgese G, Chiarelli F. Verrotti A, et al. J Paediatr Child Health. 1997 Jun;33(3):242-5. doi: 10.1111/j.1440-1754.1997.tb01588.x. J Paediatr Child Health. 1997. PMID: 9259301

3

Platelet count and function in children receiving sodium valproate.

Verrotti A, Greco R, Matera V, Altobelli E, Morgese G, Chiarelli F. Verrotti A, et al. Pediatr Neurol. 1999 Sep;21(3):611-4. doi: 10.1016/s0887-8994(99)00060-0. Pediatr Neurol. 1999. PMID: 10513686

4

Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine.

Verrotti A, Pascarella R, Trotta D, Giuva T, Morgese G, Chiarelli F. Verrotti A, et al. Epilepsy Res. 2000 Oct;41(3):253-7. doi: 10.1016/s0920-1211(00)00150-9. Epilepsy Res. 2000. PMID: 10962216 Clinical Trial.

5

Thyroid hormones in epileptic children receiving carbamazepine and valproic acid.

Verrotti A, Basciani F, Morresi S, Morgese G, Chiarelli F. Verrotti A, et al. Pediatr Neurol. 2001 Jul;25(1):43-6. doi: 10.1016/s0887-8994(01)00279-x. Pediatr Neurol. 2001. PMID: 11483395

6

Valproate-induced hyperammonemic encephalopathy.

Verrotti A, Trotta D, Morgese G, Chiarelli F. Verrotti A, et al. Metab Brain Dis. 2002 Dec;17(4):367-73. doi: 10.1023/a:1021918104127. Metab Brain Dis. 2002. PMID: 12602513 Review.

7

Valproate-induced insulin resistance and obesity in children.

Verrotti A, la Torre R, Trotta D, Mohn A, Chiarelli F. Verrotti A, et al. Horm Res. 2009;71(3):125-31. doi: 10.1159/000197868. Epub 2009 Feb 3. Horm Res. 2009. PMID: 19188736 Review.

8

Weight gain and insulin resistance in children treated with valproate: the influence of time.

Masuccio F, Verrotti A, Chiavaroli V, de Giorgis T, Giannini C, Chiarelli F, Mohn A. Masuccio F, et al. Among authors: verrotti a. J Child Neurol. 2010 Aug;25(8):941-7. doi: 10.1177/0883073809349461. Epub 2010 Mar 4. J Child Neurol. 2010. PMID: 20207607

9

Treatment options for paediatric diabetes.

Verrotti A, Chiuri RM, Blasetti A, Mohn A, Chiarelli F. Verrotti A, et al. Expert Opin Pharmacother. 2010 Oct;11(15):2483-95. doi: 10.1517/14656566.2010.506479. Expert Opin Pharmacother. 2010. PMID: 20666700 Review.

10

Pharmacotherapy for children and adolescents with epilepsy.

Verrotti A, Loiacono G, Coppola G, Spalice A, Mohn A, Chiarelli F. Verrotti A, et al. Expert Opin Pharmacother. 2011 Feb;12(2):175-94. doi: 10.1517/14656566.2010.517194. Epub 2011 Jan 6. Expert Opin Pharmacother. 2011. PMID: 21208135 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

702 results

Search Page

Filters